Ropes & Gray, Slaughter and May, Davis Polk & Wardwell and Sullivan & Cromwell have all picked up advisory roles as pharmaceutical group Shire moves to buy US firm Dyax.
Your limit of 1 article in 30 days is up. Please login for full access or subscribe.
Corporate users - click here for simple access (no password needed).
For more information, please contact [email protected]
